Medications

Inhalation drug may prevent severe pneumonia

Overly active immune cells are often behind lung damage in diseases such as COVID-19. Researchers at the Technical University of Munich (TUM) have developed an RNA agent for a lung spray that slows the activity of these cells, ...

Diseases, Conditions, Syndromes

Protein inhibits development of COVID-19 in live animals

A mammalian protein previously shown by UT Southwestern microbiologists to inhibit the virus that causes COVID-19 in cell culture also protected live mouse models, significantly limiting infection in the lung cells and diminishing ...

Medications

Novel drug could treat long COVID and prevent re-infection

A new drug developed by QIMR Berghofer could transform the treatment of COVID-19 by potentially protecting against infection by any SARS-CoV-2 variant and reversing the persistent inflammation that is a major driver of debilitating ...

page 8 from 40